Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1065 | 1023 | 1160 | 829 | 1567 | 2496 |
Fund Return | 6.53% | 2.35% | 15.96% | -6.08% | 9.4% | 9.58% |
Place in category | 453 | 501 | 494 | 455 | 299 | 257 |
% in Category | 84 | 94 | 93 | 89 | 65 | 66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artisan International Value Instl | 22.23B | 14.63 | 11.12 | 8.54 | ||
Artisan International Value Advisor | 10.85B | 14.57 | 11.02 | - | ||
Artisan Mid Cap Advisor | 4.31B | 6.62 | -5.94 | - | ||
Artisan Mid Cap Institutional | 4.31B | 6.71 | -5.85 | 9.84 | ||
Artisan International Small Cap Ins | 3.37B | 7.55 | -3.14 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 13.87B | 19.74 | 8.41 | 13.11 | ||
T. Rowe Price Mid-Cap Growth I | 13.01B | 9.72 | 2.33 | - | ||
T. Rowe Price Mid-Cap Growth | 12.21B | 9.61 | 2.19 | 11.17 | ||
Vanguard Mid-Cap Growth Index Admir | 12.13B | 11.40 | 1.70 | 10.58 | ||
T. Rowe Price New Horizons I | 10.31B | 3.47 | -8.65 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 4.64 | 588.67 | -1.16% | |
Tyler Technologies | US9022521051 | 3.76 | 600.61 | -0.36% | |
Ascendis Pharma AS | US04351P1012 | 3.56 | 125.77 | +0.39% | |
Spotify Tech | LU1778762911 | 3.55 | 377.73 | -1.76% | |
West Pharmaceutical Services | US9553061055 | 3.32 | 314.77 | -0.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Strong Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | BUY |
Summary | Sell | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review